Skip to content
Screener

Clarivate CLVT Life Sciences & Healthcare — Revenue

Other segment segments

Academia & Government Group
$300.3M-5.7%
Intellectual Property Group
$198.3M-2.1%

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Revenue
$180M+11.1%
Neogen logo
NEOGLife Sciences — Revenue
$1.5M0.0%
PTC Therapeutics logo
PTCTLife Science — Revenue
$272.55M-76.8%
CryoPort, Inc. logo
CYRXLife Sciences Products — Revenue
$21.54M+7.8%
CryoPort, Inc. logo
CYRXLife Sciences Services — Revenue
$28.68M+10.2%
Ecolab logo
ECLGlobal Life Sciences — Revenue
$221M+15.5%

Other financials

Income statement

See full
Revenue$587.3M-5.5%
Gross profit$401.8M-3.8%
Operating income-$200.2M-3,001%
Net income-$268.6M-273%
EPS (diluted)-$0.42-282%

Balance sheet

See full
Cash & equivalents$217.7M-40.0%
Total debt$4.3B-7.4%
Total equity$4.5B-9.1%
Total assets$10.5B-8.2%

Cash flow

See full
Operating cash flow$98.7M-15.1%
CapEx$54.7M-17.1%
Free cash flow$44.0M-12.5%

Valuation

See full
Market cap$1.18B-53.4%
Enterprise value$5.29B-22.7%
P/S0.5×-0.5×

Profitability

See full
Gross margin66.8%+0.8pp
Operating margin-3.5%+5.5pp
Net margin-14%-2.3pp
FCF margin13.6%-0.3pp

Returns & leverage

See full
Return on equity-7.1%-0.8pp
Debt / equity0.0×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Clarivate’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 6:04 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001764046-26-000091
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other costs(7.5)(7.1)(13.2)(12.3)
IP Adjusted EBITDA$86.4$84.6$171.8$163.4
Life Sciences & Healthcare
Revenues$88.7$100.4$182.0$198.7
People-related costs(43.6)(46.2)(87.3)(93.0)
Royalties and other product costs(9.0)(9.4)(17.8)(18.2)
Technology costs(6.5)(6.6)(13.1)(13.6)
Outside service costs(1.7)(3.0)(3.7)(5.6)

Item 1. Financial Statements (Unaudited)

FAQ

What is Clarivate's life sciences & healthcare — revenue?
Clarivate (CLVT) reported life sciences & healthcare — revenue of $88.7M in Q2 2026.
How has Clarivate's life sciences & healthcare — revenue changed year-over-year?
Clarivate's life sciences & healthcare — revenue decreased by 11.7% year-over-year, from $100.4M to $88.7M.
What is the long-term trend for Clarivate's life sciences & healthcare — revenue?
Over 3 years (2022 to 2025), Clarivate's life sciences & healthcare — revenue has grown at a -4.9% compound annual growth rate (CAGR), from $452.6M to $389.8M.
What does life sciences & healthcare — revenue mean?
This represents the total gross income generated by the Life Sciences & Healthcare segment from its data, software, and workflow solutions. It serves as a primary indicator of the segment's market demand and its ability to monetize its specialized information services within the healthcare and life sciences industries.

Ask your AI about Clarivate's life sciences & healthcare — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude